Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ended December ...

Inogen reported total revenue of $81.7 million for the fourth quarter of 2025, a 2% increase compared to the same period last year, primarily driven by higher growth in international ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited ...

“2024 was a very successful year for Inogen (INGN). We drove a return to revenue growth, improved profitability and disciplined cost management. Achievements in the quarter included the launch of Rove ...

Welcome to Inogen's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November 5, 2025. I'd now like to turn the call over to ...

Inogen Inc saw positive EPS revisions and negative EPS revisions in the last 90 days. See Inogen Inc’s stock price’s past reactions to earnings here. According to InvestingPro, Inogen Inc’s Financial ...

BEVERLY, Mass. (AP) — BEVERLY, Mass. (AP) — Inogen Inc. (INGN) on Tuesday reported a loss of $7.1 million in its fourth quarter. The Beverly, Massachusetts-based company said it had a loss of 26 cents ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced preliminary, ...